ARTICLES BY BOBBY GEORGE
-
![Conducting Clinical Trials In India: Opportunities And Challenges]( "India's Draft Pharmaceutical Policy — A Game Changer")
India's Draft Pharmaceutical Policy — A Game Changer9/26/2017The Indian pharmaceutical sector is largely fueled by exports. Over the last five years, many changes have affected the pharmaceutical sector, which have necessitated a fresh, comprehensive national policy to maintain and enhance its global competitive edge in quality and prices.
Bobby George
Bobby George, Ph.D., is head of regulatory affairs at Reliance Life Sciences (Navi Mumbai, India). He is responsible for regulatory services across all of the company’s business verticals (pharmaceuticals, biosimilars, plasma proteins, etc.). He has a doctorate in pharmacology and over 20 years of industry experience. He has written 34 publications in peer-reviewed journals and three book chapters. George recently authored and published a book titled “The Act that Wasn’t,” in which he deliberates on the “Acts” (laws) and “acts” (wrong deeds) of those in the drug and healthcare industry, citing several examples of the unholy nexus between stakeholders.